Purigen Biosystems

About:

Purigen Biosystems' innovative products offer a truly transformative automated solution for DNA and RNA purification.

Website: https://www.purigenbio.com/

Twitter/X: purigenbio

Top Investors: Agilent Technologies, Cota Capital, 5AM Ventures, Roche Venture Fund, StartX (Stanford-StartX Fund)

Description:

Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Their proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, their technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Their Ionic Purification System and Kits combine to provide researchers with a fast, efficient, and effective alternative for automated nucleic acid purification.

Total Funding Amount:

$93.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)purigenbio.com

Founders:

Amy Hiddessen, Juan Santiago, Klint Rose

Number of Employees:

11-50

Last Funding Date:

2021-04-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai